Wave Life Sciences Ownership | Who Owns Wave Life Sciences?

Overview Forecast RevenueFinancials Chart Transcripts

Wave Life Sciences Ownership Summary

Wave Life Sciences is owned by 80.76% institutional investors, 16.35% insiders, and 2.89% retail investors. Ra capital management is the largest institutional shareholder, holding 13.85% of WVE shares. BB Biotech AG Ord is the top mutual fund, with 2.68% of its assets in Wave Life Sciences shares.

WVE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Wave Life Sciences	80.76%	16.35%	2.89%
Sector	Healthcare Stocks	279.42%	10.64%	-190.05%
Industry	Biotech Stocks	64.05%	10.69%	25.27%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ra capital management	18.20M	13.85%	$225.16M
Adage capital partners gp	9.62M	7.32%	$119.03M
Blackrock funding, inc. /de	9.36M	7.12%	$115.79M
Maverick capital	8.26M	6.28%	$102.19M
Blackrock	6.74M	5.21%	$33.63M
M28 capital management lp	5.66M	4.31%	$70.07M
Price t rowe associates inc /md/	5.10M	3.88%	$63.07M
Kynam capital management, lp	4.90M	3.73%	$60.61M
Artal group	4.57M	3.53%	$22.79M
Bellevue group	4.09M	3.11%	$50.65M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
M28 capital management lp	5.66M	68.79%	$70.07M
Kynam capital management, lp	4.90M	3.58%	$60.61M
Ra capital management	18.20M	3.00%	$225.16M
683 capital management	3.79M	2.90%	$46.82M
Bioimpact capital	1.49M	2.62%	$18.42M
Affinity asset advisors	1.50M	2.49%	$18.55M
Stempoint capital lp	721.21K	2.23%	$8.92M
Siren	3.75M	2.05%	$46.39M
Maverick capital	8.26M	1.84%	$102.19M
Silverarc capital management	608.90K	1.65%	$7.53M

Top Buyers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	9.36M	0.00%	2.06M
Price t rowe associates inc /md/	5.10M	0.01%	1.97M
Pfizer	1.88M	0.89%	1.88M
Loomis sayles & co l p	1.66M	0.03%	1.66M
Bioimpact capital	1.49M	2.62%	864.77K

Top Sellers

Holder	Shares	% Assets	Change
Siren	3.75M	2.05%	-1.97M
Maverick capital	8.26M	1.84%	-1.79M
Takeda pharmaceutical	-	-	-1.35M
Maven securities	170.00K	0.05%	-680.00K
Ikarian capital	-	-	-544.26K

New Positions

Holder	Shares	% Assets	Change	Value
Pfizer	1.88M	0.89%	1.88M	$23.19M
Loomis sayles & co l p	1.66M	0.03%	1.66M	$20.55M
Voloridge investment management	845.83K	0.04%	845.83K	$10.46M
F/m investments	226.03K	0.10%	226.03K	$2.80M
Eam investors	214.72K	0.38%	214.72K	$2.66M

Sold Out

Holder	Change
National bank of canada /fi/	-1.00
Allworth financial lp	-3.00
Nelson, van denburg & campbell wealth management group	-12.00
Capital performance advisors llp	-13.00
Stephens consulting	-40.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	202	6.88%	131,254,882	2.11%	80	0.84%	116	-3.33%	51	34.21%
Dec 31, 2024	81	-50.61%	32,943,703	-72.58%	25	0.31%	57	-40.00%	14	-64.10%
Sep 30, 2024	163	10.88%	118,791,972	26.74%	89	1.71%	95	15.85%	39	-15.22%
Jun 30, 2024	147	9.70%	93,731,224	2.54%	72	1.45%	82	-6.82%	46	43.75%
Mar 31, 2024	134	13.56%	91,412,722	0.25%	70	1.02%	88	2.33%	32	190.91%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
BB Biotech AG Ord	4.09M	2.68%	-
iShares Russell 2000 ETF	2.69M	1.69%	-43.59K
PRIMECAP Odyssey Aggressive Growth	2.39M	1.50%	-46.94K
T. Rowe Price New Horizons	2.13M	1.37%	323.96K
US Small-Cap Growth II Equity Comp	2.13M	1.37%	513.86K
Vanguard Institutional Extnd Mkt Idx Tr	1.86M	1.17%	-7.40K
Loomis Sayles Small Cap Growth Instl	1.85M	1.16%	-32.63K
Artisan International Small-Mid Investor	1.51M	0.97%	-102.46K
Artisan Non-U.S. Small-Mid Growth Comp	1.51M	0.97%	-102.46K
T. Rowe Price Health Sciences	1.07M	0.69%	172.73K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 05, 2025	TAKANASHI KEN	-	Sell	$42.63K
Aug 05, 2025	Tan Aik Na	-	Sell	$9.86K
Jun 13, 2025	Verdine Gregory L.	-	Sell	$208.50K
Mar 20, 2025	HENRY CHRISTIAN O	-	Sell	$102.57K
Mar 07, 2025	BOLNO PAUL	President and CEO	Sell	$1.62M

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	2
2025 Q2	-	1
2025 Q1	-	2
2024 Q4	-	8
2024 Q3	1	2

WVE Ownership FAQ

Who Owns Wave Life Sciences?

Wave Life Sciences shareholders are primarily institutional investors at 80.76%, followed by 16.35% insiders and 2.89% retail investors. The average institutional ownership in Wave Life Sciences's industry, Biotech Stocks , is 64.05%, which Wave Life Sciences exceeds.

Who owns the most shares of Wave Life Sciences?

Wave Life Sciences’s largest shareholders are Ra capital management (18.2M shares, 13.85%), Adage capital partners gp (9.62M shares, 7.32%), and Blackrock funding, inc. /de (9.36M shares, 7.12%). Together, they hold 28.29% of Wave Life Sciences’s total shares outstanding.

Does Blackrock own Wave Life Sciences?

Yes, BlackRock owns 5.21% of Wave Life Sciences, totaling 6.74M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 33.63M$. In the last quarter, BlackRock increased its holdings by 363.48K shares, a 5.70% change.

Who is Wave Life Sciences’s biggest shareholder by percentage of total assets invested?

M28 capital management lp is Wave Life Sciences’s biggest shareholder by percentage of total assets invested, with 68.79% of its assets in 5.66M Wave Life Sciences shares, valued at 70.07M$.

Who is the top mutual fund holder of Wave Life Sciences shares?

BB Biotech AG Ord is the top mutual fund holder of Wave Life Sciences shares, with 2.68% of its total shares outstanding invested in 4.09M Wave Life Sciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools